Not checkedNot checked for notices yet.
Inhibition of RANK signaling as a potential immunotherapy in breast cancer
C Gómez-Aleza, E González-Suárez
OncoImmunology · 2021
doi:10.1080/2162402x.2021.1923156 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
RANK signaling in mouse mammary tumor cells exerts an immunosuppressive environment by promoting the infiltration of pro-tumorigenic neutrophils and preventing CD8 T cell recruitment. Single-agent denosumab led to an increased tumor immune infiltration by lymphocytes and CD8 + T cells in breast cancer patients, supporting the immunomodulatory role of RANK signaling.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.